Rare diseases
Investigational molecules
Locations
Back to Sweden745 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors
SwedenStudy on Gallium (68Ga) Tezatabep Matraxetan PET for Evaluating HER2 Status in Patients with Gastro-Esophageal and HER2-Low Breast Cancer
SwedenStudy on the Effects of JNJ-63733657 and Florquinitau F18 in Patients with Early Alzheimer's Disease
SwedenStudy on Imaging with 89Zr-Atezolizumab to Monitor Immune Responses in Patients with Metastatic Triple Negative Breast Cancer Using Atezolizumab and Drug Combination
SwedenStudy on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children
SwedenStudy on Octreotide for Nutritional Recovery After Surgery in Esophageal or Gastric Cancer Patients
SwedenStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
SwedenStudy of Mosunetuzumab for Patients with Early Relapse of Follicular Lymphoma
SwedenStudy of Nivolumab, Ipilimumab, and UV1 Vaccine for Patients with Malignant Pleural Mesothelioma After Initial Chemotherapy
SwedenStudy of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer
SwedenStudy on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
SwedenStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
SwedenThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.
Innovative research comparing various treatment protocols and investigating survival outcomes.
Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.
Focus on prevention and immune response in various age groups.
Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.
Emphasis on improving patient outcomes and testing novel drug combinations.
Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.
Studies evaluating both novel and existing therapeutic approaches.
Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.
Focus on lifestyle interventions combined with pharmaceutical approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
